Background illustration for clinical trials search

Paid Clinical Trials Pittsburgh

Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

for
Uveal Melanoma
Location: Pittsburgh PA, Columbus OH, Washington D.C. DC,
Sponsor: Diwakar Davar

Sex: All

Age: 18+

Code: NCT06070012

Phase 2, Recruiting

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

for
SCLC
Location: Pittsburgh PA, Cleveland OH, Buffalo NY, Fairfax VA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06179069

Phase 1, Recruiting

Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC),
Location: Pittsburgh PA
Sponsor: Dan Zandberg

Sex: All

Age: 18+

Code: NCT06052839

Phase 2, Recruiting

XTX301 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Pittsburgh PA, Canton OH, Cleveland OH, Columbus OH,
Sponsor: Xilio Development, Inc.

Sex: All

Age: 18+

Code: NCT05684965

Phase 1, Phase 2, Recruiting

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

for
Metastatic Colorectal Carcinoma,
Location: Pittsburgh PA, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05803382

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Pittsburgh PA, Morgantown WV, Washington D.C. DC,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase 3, Recruiting

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

for
Advanced Malignant Solid Neoplasm,
Location: Pittsburgh PA, Bethesda MD, Trumbull CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691491

Phase 1, Phase 2, Recruiting

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

for
Platinum-Resistant Fallopian Tube Carcinoma,
Location: Pittsburgh PA
Sponsor: Ronald Buckanovich

Sex: Female

Age: 18+

Code: NCT05538091

Phase 2, Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

for
Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC),
Location: Pittsburgh PA, Chapel Hill NC, Lake Success NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06413680

Phase 1, Phase 2, Recruiting

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Pittsburgh PA, Boston MA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05372640

Phase 1, Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

for
Metastatic Solid Tumor, Advanced Solid Tumor
Location: Pittsburgh PA, Fairfax VA, Detroit MI, New York NY,
Sponsor: Coherus Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06657144

Phase 1, Recruiting

A Study of BGB-11417 in Participants With Myeloid Malignancies

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes,
Location: Pittsburgh PA, Milwaukee WI, Tampa FL, Houston TX
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT04771130

Phase 1, Phase 2, Recruiting

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

for
Advanced Lung Neuroendocrine Tumor,
Location: Pittsburgh PA, Cleveland OH, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04665739

Phase 2, Recruiting

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

for
Gastric Cancer, Esophageal Adenocarcinoma,
Location: Pittsburgh PA
Sponsor: Anwaar Saeed

Sex: All

Age: 18+

Code: NCT03539822

Phase 1, Phase 2, Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

for
Thrombocythemia, Essential, Primary Myelofibrosis,
Location: Pittsburgh PA, Columbus OH, Ann Arbor MI, Durham NC
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06351631

Phase 3, Recruiting

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

for
Unresectable Melanoma, Metastatic Melanoma,
Location: Pittsburgh PA, Cincinnati OH, New York NY,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05361174

Phase 1, Phase 2, Recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Pittsburgh PA, Nashville TN, Fort Worth TX,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06462794

Phase 1, Recruiting

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

for
Oropharyngeal Cancer, HPV-Related Carcinoma
Location: Pittsburgh PA, Omaha NE, Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06305676

Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Pittsburgh PA, Canton OH, Cleveland OH, Frederick MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase 3, Recruiting

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: Pittsburgh PA, New York NY
Sponsor: AskGene Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05867420

Phase 1, Phase 2, Recruiting